uniQure (QURE)
(Delayed Data from NSDQ)
$8.04 USD
+0.41 (5.38%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $8.04 +0.01 (0.06%) 7:58 PM ET
2-Buy of 5 2
D Value F Growth A Momentum D VGM
Price, Consensus and EPS Surprise
QURE 8.04 +0.41(5.38%)
Will QURE be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for QURE based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for QURE
Biotech Stock Roundup: KYMR, IDYA, QURE Soar on Study Data, HLVX Tanks on Study Failure
Wall Street Analysts Think uniQure (QURE) Could Surge 195.8%: Read This Before Placing a Bet
QURE: What are Zacks experts saying now?
Zacks Private Portfolio Services
uniQure (QURE) Soars on New Huntington's Disease Study Data
uniQure (QURE) Surges 76.5%: Is This an Indication of Further Gains?
Down -29.74% in 4 Weeks, Here's Why You Should You Buy the Dip in uniQure (QURE)
Other News for QURE
uniQure Announces Closing of Sale of Manufacturing Facility to Genezen
Sangamo Therapeutics: A Bust Or Billion Dollar Valuation In The Remaking
uniQure Advances with Strategic Facility Sale and Partnership Deals
uniQure announces closing of sale of manufacturing facility to Genezen
Largest borrow rate increases among liquid names